Shuttle Pharmaceuticals Holdings, Inc. Finalizes Agreements for Phase 2 Clinical Trial Enrollment: Press Release Analysis
Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation trading as SHPH on the Nasdaq Stock Market LLC, recently announced significant progress in their clinical trial endeavors. On October 28, 2024, the company issued a press release detailing the completion of agreements with all six intended site enrollment locations for the administration of the Phase 2 clinical […]
More Stories
CDbio Achieves Self Reported Market Capitalization of $1.00 Billion (MCD)
CDbio (MCD) traded flat against the US dollar during the 1 day period ending at 16:00 PM ET on October...
Kyrrex (KRRX) Price Hits $0.0776
Kyrrex (KRRX) traded 0.2% lower against the dollar during the 1 day period ending at 16:00 PM ET on October...
Chromia Trading 1.6% Lower Over Last Week (CHR)
Chromia (CHR) traded 0.8% lower against the U.S. dollar during the one day period ending at 16:00 PM ET on...
xSUSHI (XSUSHI) Price Reaches $1.05 on Top Exchanges
xSUSHI (XSUSHI) traded up 0.5% against the U.S. dollar during the 24 hour period ending at 16:00 PM E.T. on...
Loom Network Reaches One Day Trading Volume of $2.47 Million (LOOM)
Loom Network (LOOM) traded 1.2% lower against the US dollar during the 24 hour period ending at 16:00 PM E.T....
Kforce Inc. (NASDAQ:KFRC) to Issue Quarterly Dividend of $0.38
Kforce Inc. (NASDAQ:KFRC – Get Free Report) announced a quarterly dividend on Wednesday, October 30th, Wall Street Journal reports. Stockholders...